mexichem specialty compounds limited

Live MatureLargeDeclining

mexichem specialty compounds limited Company Information

Share MEXICHEM SPECIALTY COMPOUNDS LIMITED

Company Number

01572669

Shareholders

mexichem resinas vinilicas s.a. de c.v.

Group Structure

View All

Industry

Manufacture of plastics in primary forms

 +1

Registered Address

c/o mexichem 8 beler way, leicester road industrial estate, melton mowbray, leicestershire, LE13 0DG

mexichem specialty compounds limited Estimated Valuation

£61.7m

Pomanda estimates the enterprise value of MEXICHEM SPECIALTY COMPOUNDS LIMITED at £61.7m based on a Turnover of £79.4m and 0.78x industry multiple (adjusted for size and gross margin).

mexichem specialty compounds limited Estimated Valuation

£12.5m

Pomanda estimates the enterprise value of MEXICHEM SPECIALTY COMPOUNDS LIMITED at £12.5m based on an EBITDA of £2.2m and a 5.81x industry multiple (adjusted for size and gross margin).

mexichem specialty compounds limited Estimated Valuation

£279.5m

Pomanda estimates the enterprise value of MEXICHEM SPECIALTY COMPOUNDS LIMITED at £279.5m based on Net Assets of £161.8m and 1.73x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Mexichem Specialty Compounds Limited Overview

Mexichem Specialty Compounds Limited is a live company located in melton mowbray, LE13 0DG with a Companies House number of 01572669. It operates in the manufacture of plastics in primary forms sector, SIC Code 20160. Founded in July 1981, it's largest shareholder is mexichem resinas vinilicas s.a. de c.v. with a 100% stake. Mexichem Specialty Compounds Limited is a mature, large sized company, Pomanda has estimated its turnover at £79.4m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Mexichem Specialty Compounds Limited Health Check

Pomanda's financial health check has awarded Mexichem Specialty Compounds Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 3 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

7 Strong

positive_score

2 Regular

positive_score

3 Weak

size

Size

annual sales of £79.4m, make it larger than the average company (£19.9m)

£79.4m - Mexichem Specialty Compounds Limited

£19.9m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -4%, show it is growing at a slower rate (7%)

-4% - Mexichem Specialty Compounds Limited

7% - Industry AVG

production

Production

with a gross margin of 17.1%, this company has a higher cost of product (22.3%)

17.1% - Mexichem Specialty Compounds Limited

22.3% - Industry AVG

profitability

Profitability

an operating margin of -0.6% make it less profitable than the average company (4.9%)

-0.6% - Mexichem Specialty Compounds Limited

4.9% - Industry AVG

employees

Employees

with 227 employees, this is above the industry average (86)

227 - Mexichem Specialty Compounds Limited

86 - Industry AVG

paystructure

Pay Structure

on an average salary of £50.4k, the company has an equivalent pay structure (£42.9k)

£50.4k - Mexichem Specialty Compounds Limited

£42.9k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £349.7k, this is more efficient (£249.9k)

£349.7k - Mexichem Specialty Compounds Limited

£249.9k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 43 days, this is near the average (46 days)

43 days - Mexichem Specialty Compounds Limited

46 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 58 days, this is slower than average (34 days)

58 days - Mexichem Specialty Compounds Limited

34 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 42 days, this is less than average (54 days)

42 days - Mexichem Specialty Compounds Limited

54 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 62 weeks, this is more cash available to meet short term requirements (11 weeks)

62 weeks - Mexichem Specialty Compounds Limited

11 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 9%, this is a lower level of debt than the average (40.6%)

9% - Mexichem Specialty Compounds Limited

40.6% - Industry AVG

MEXICHEM SPECIALTY COMPOUNDS LIMITED financials

EXPORTms excel logo

Mexichem Specialty Compounds Limited's latest turnover from December 2023 is £79.4 million and the company has net assets of £161.8 million. According to their latest financial statements, Mexichem Specialty Compounds Limited has 227 employees and maintains cash reserves of £13.6 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Jan 2011Dec 2009
Turnover79,390,000107,139,00098,614,00090,336,000107,089,00099,971,00060,837,00046,384,00042,139,00047,391,00045,491,00053,006,00045,060,00044,185,00036,668,000
Other Income Or Grants
Cost Of Sales65,848,00090,549,00083,907,00077,111,00088,330,00080,016,00050,225,00038,039,00036,145,00041,203,00038,636,00046,247,00037,774,00036,329,00030,507,000
Gross Profit13,542,00016,590,00014,707,00013,225,00018,759,00019,955,00010,612,0008,345,0005,994,0006,188,0006,855,0006,759,0007,286,0007,856,0006,161,000
Admin Expenses14,021,00013,373,00013,883,0003,778,00012,737,00011,297,0008,364,0007,605,0007,711,0009,952,0007,566,0007,951,0007,558,0006,591,0005,403,000
Operating Profit-479,0003,217,000824,0009,447,0006,022,0008,658,0002,248,000740,000-1,717,000-3,764,000-711,000-1,192,000-272,0001,265,000758,000
Interest Payable144,000233,000224,000190,000597,00018,00025,000
Interest Receivable369,000323,000345,000404,000606,000587,000247,000345,000316,00061,00012,0003,00011,0007,00018,000
Pre-Tax Profit-254,0003,307,000945,0009,241,0005,401,00022,566,00011,072,0002,282,000-1,612,000-3,908,000-703,000-1,268,000-729,0004,331,000751,000
Tax298,000-1,076,000-89,000-631,000-870,000-1,751,000-411,000-103,000332,00067,000394,000454,000299,000-1,006,000-239,000
Profit After Tax44,0002,231,000856,0008,610,0004,531,00020,815,00010,661,0002,179,000-1,280,000-3,841,000-309,000-814,000-430,0003,325,000512,000
Dividends Paid3,173,000
Retained Profit44,0002,231,000856,0008,610,0001,358,0007,249,0001,713,0002,179,000-1,280,000-3,841,000-309,000-814,000-430,0003,325,000512,000
Employee Costs11,450,00011,982,00011,401,00010,208,00010,240,0009,345,0005,620,0004,643,0004,714,0004,323,0004,588,0004,558,0004,455,0004,643,0004,317,000
Number Of Employees227248251248234220140114121117113115120120129
EBITDA*2,153,0005,787,0004,488,00012,880,0008,671,00010,943,0004,055,0002,470,000145,000-1,337,0001,748,0001,295,0002,110,0003,541,0003,202,000

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Jan 2011Dec 2009
Tangible Assets18,588,000159,929,000164,974,000139,179,000137,765,000135,945,000131,210,000126,648,000127,694,000116,119,00017,147,00018,618,00020,190,00021,658,00022,814,000
Intangible Assets2,363,00087,000117,000616,0001,257,0001,878,0002,430,0003,003,0003,633,0004,305,0004,981,0005,648,0006,330,0006,714,00010,056,000
Investments & Other116,129,000116,129,000112,966,000112,966,000112,965,000112,965,000112,965,000112,965,000112,965,000100,502,000
Debtors (Due After 1 year)5,891,00010,778,00014,059,000
Total Fixed Assets142,971,000149,238,000151,032,000139,795,000139,022,000137,823,000133,640,000129,651,000131,327,000120,424,00022,128,00024,266,00026,520,00028,372,00032,870,000
Stock & work in progress7,674,00011,577,00014,252,00011,521,00014,804,00018,792,00014,966,0006,116,0005,151,0006,854,0008,059,0006,607,0007,588,0006,532,0005,888,000
Trade Debtors9,425,00014,155,00017,979,00015,994,00014,134,00017,173,00016,921,0008,994,0007,060,0006,750,0006,789,0006,815,0008,354,0006,846,000
Group Debtors2,623,0002,003,0001,932,00012,283,00013,404,00013,125,000393,0006,115,0005,181,0004,246,0001,744,0001,280,000334,00044,000946,000
Misc Debtors1,504,000744,000713,000739,0001,154,0001,269,0001,189,000389,000689,000794,000516,000374,000549,0007,894,0001,284,000
Cash13,555,00011,264,0003,348,0006,126,0007,534,0006,925,00017,647,0001,484,0001,555,0004,829,0005,226,0004,347,0004,554,0001,449,0002,513,000
misc current assets125,000125,000
total current assets34,781,00040,279,00039,057,00047,828,00051,933,00057,284,00051,116,00023,098,00019,636,00023,473,00022,334,00019,548,00021,504,00015,919,00017,477,000
total assets177,752,000189,517,000190,089,000187,623,000190,955,000195,107,000184,756,000152,749,000150,963,000143,897,00044,462,00043,814,00048,024,00044,291,00050,347,000
Bank overdraft23,358,000
Bank loan
Trade Creditors 10,629,0009,177,00011,234,00011,230,00010,144,0009,700,0007,340,0005,709,0007,016,00010,190,0008,190,0005,485,0005,867,0004,495,0005,184,000
Group/Directors Accounts198,000
other short term finances
hp & lease commitments668,000712,000670,000638,000391,000
other current liabilities12,537,00017,418,00015,216,00022,692,00030,299,00030,203,0001,968,0001,169,0001,782,0001,875,0001,229,0003,790,000698,000731,000
total current liabilities11,297,00022,426,00029,322,00027,084,00033,227,00039,999,00037,543,0007,677,0008,185,00011,972,00010,065,0006,714,0009,657,0005,193,00029,471,000
loans5,164,0006,034,0007,164,0003,326,000
hp & lease commitments1,930,0002,582,0003,017,0003,582,0001,663,000
Accruals and Deferred Income2,617,0001,907,000
other liabilities25,000169,000101,00030,00028,00038,0006,00015,0004,000
provisions2,734,0004,082,0003,562,0004,344,0003,116,0002,242,0002,034,0002,698,0002,832,0003,620,0004,524,0005,126,000
total long term liabilities4,689,0005,368,0005,025,0005,653,0003,472,0002,210,0001,564,0001,136,0001,021,0001,349,0001,416,0001,810,0002,262,0002,563,000
total liabilities15,986,00027,794,00034,347,00032,737,00036,699,00042,209,00039,107,0008,813,0009,206,00013,321,00011,481,0008,524,00011,919,0007,756,00029,471,000
net assets161,766,000161,723,000155,742,000154,886,000154,256,000152,898,000145,649,000143,936,000141,757,000130,576,00032,981,00035,290,00036,105,00036,535,00020,876,000
total shareholders funds161,766,000161,723,000155,742,000154,886,000154,256,000152,898,000145,649,000143,936,000141,757,000130,576,00032,981,00035,290,00036,105,00036,535,00020,876,000
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Jan 2011Dec 2009
Operating Activities
Operating Profit-479,0003,217,000824,0009,447,0006,022,0008,658,0002,248,000740,000-1,717,000-3,764,000-711,000-1,192,000-272,0001,265,000758,000
Depreciation1,844,0002,541,0003,153,0002,781,0002,008,0001,660,0001,182,0001,081,0001,182,0001,751,0001,784,0001,805,0001,742,0001,618,0001,853,000
Amortisation788,00029,000511,000652,000641,000625,000625,000649,000680,000676,000675,000682,000640,000658,000591,000
Tax298,000-1,076,000-89,000-631,000-870,000-1,751,000-411,000-103,000332,00067,000394,000454,000299,000-1,006,000-239,000
Stock-3,903,000-2,675,0002,731,000-3,283,000-3,988,0003,826,0008,850,000965,000-1,703,000-1,205,0001,452,000-981,0007,588,0006,532,0005,888,000
Debtors-8,237,000-7,003,0005,667,000324,000-2,875,00013,064,0003,005,0002,568,0001,140,0002,741,000580,000-768,0009,237,0007,938,0009,076,000
Creditors1,452,000-2,057,0004,0001,086,000444,0002,360,0001,631,000-1,307,000-3,174,0002,000,0002,705,000-382,0005,867,0004,495,0005,184,000
Accruals and Deferred Income-15,154,000-4,171,0004,109,000-7,476,000-7,607,00096,00028,235,000799,000-613,000-93,000646,000-2,561,0003,790,000698,000731,000
Deferred Taxes & Provisions2,734,000-4,082,000520,000-782,0001,228,000874,000208,000-664,000-134,000-788,000-904,0004,524,0005,126,000
Cash flow from operations3,623,0008,161,000-3,968,0009,338,0006,719,000-4,014,00022,529,000-1,466,000-3,411,000-1,033,0002,673,000-349,000-235,000-1,616,000-6,086,000
Investing Activities
capital expenditure136,433,0002,505,000-28,960,000-4,206,000-3,848,000-6,468,000-5,796,000-54,000-12,765,000-100,723,000-321,000-233,000-28,902,000-30,648,000-35,314,000
Change in Investments3,163,0001,00012,463,000100,502,000
cash flow from investments136,433,000-658,000-28,960,000-4,207,000-3,848,000-6,468,000-5,796,000-54,000-25,228,000-201,225,000-321,000-233,000-28,902,000-30,648,000-35,314,000
Financing Activities
Bank loans
Group/Directors Accounts198,000
Other Short Term Loans
Long term loans-5,164,000-870,000-1,130,0003,838,0003,326,000
Hire Purchase and Lease Commitments-696,000-393,000-533,0002,166,0002,054,000
other long term liabilities-144,00068,00071,0002,000-10,00032,000-9,00011,0004,000
share issue-1,0003,750,000-7,980,00012,461,000101,436,000-2,000,000-1,00036,535,00033,210,00020,364,000
interest225,00090,000121,000214,0009,000587,000247,000345,000316,00061,00012,0003,00011,000-11,000-7,000
cash flow from financing-5,780,0002,645,000-1,471,000-1,760,0005,379,000619,000238,000356,00012,781,000101,497,000-1,988,0002,00036,546,00033,199,00020,555,000
cash and cash equivalents
cash2,291,0007,916,000-2,778,000-1,408,000609,000-10,722,00016,163,000-71,000-3,274,000-397,000879,000-207,0004,554,0001,449,0002,513,000
overdraft23,358,000
change in cash2,291,0007,916,000-2,778,000-1,408,000609,000-10,722,00016,163,000-71,000-3,274,000-397,000879,000-207,0004,554,0001,449,000-20,845,000

mexichem specialty compounds limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for mexichem specialty compounds limited. Get real-time insights into mexichem specialty compounds limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Mexichem Specialty Compounds Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for mexichem specialty compounds limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in LE13 area or any other competitors across 12 key performance metrics.

mexichem specialty compounds limited Ownership

MEXICHEM SPECIALTY COMPOUNDS LIMITED group structure

Mexichem Specialty Compounds Limited has no subsidiary companies.

Ultimate parent company

ORBIA ADVANCE CORPORATION SAB DE CV

#0134191

MEXICHEM RESINAS VINILICAS SA DE CV

#0087841

2 parents

MEXICHEM SPECIALTY COMPOUNDS LIMITED

01572669

MEXICHEM SPECIALTY COMPOUNDS LIMITED Shareholders

mexichem resinas vinilicas s.a. de c.v. 100%

mexichem specialty compounds limited directors

Mexichem Specialty Compounds Limited currently has 3 directors. The longest serving directors include Mr Gautam Nivarthy (Jul 2018) and Mr Daniel Delisle (Jul 2018).

officercountryagestartendrole
Mr Gautam NivarthyUnited States51 years Jul 2018- Director
Mr Daniel DelisleUnited States59 years Jul 2018- Director
Mr William MusanteUnited States60 years Jul 2022- Director

P&L

December 2023

turnover

79.4m

-26%

operating profit

-479k

-115%

gross margin

17.1%

+10.16%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

161.8m

0%

total assets

177.8m

-0.06%

cash

13.6m

+0.2%

net assets

Total assets minus all liabilities

mexichem specialty compounds limited company details

company number

01572669

Type

Private limited with Share Capital

industry

20160 - Manufacture of plastics in primary forms

22290 - Manufacture of other plastic products

incorporation date

July 1981

age

44

incorporated

UK

ultimate parent company

ORBIA ADVANCE CORPORATION SAB DE CV

accounts

Full Accounts

last accounts submitted

December 2023

previous names

alphagary limited (February 2016)

laporte alphagary limited (August 1999)

See more

accountant

-

auditor

DELOITTE LLP

address

c/o mexichem 8 beler way, leicester road industrial estate, melton mowbray, leicestershire, LE13 0DG

Bank

NATIONAL WESTMINSTER BANK PLC

Legal Advisor

-

mexichem specialty compounds limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 5 charges/mortgages relating to mexichem specialty compounds limited. Currently there are 0 open charges and 5 have been satisfied in the past.

mexichem specialty compounds limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for MEXICHEM SPECIALTY COMPOUNDS LIMITED. This can take several minutes, an email will notify you when this has completed.

mexichem specialty compounds limited Companies House Filings - See Documents

datedescriptionview/download